Get started
Author

Mauro Scharf

Observed names: M. Scharf, Scharf M
OpenAlex ID: A5004265875
International Consensus on Use of Continuous Glucose Monitoring
2017 · Thomas Danne, Revital Nimri, et al. · Diabetes Care · 2,071
PDF
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
2022 · Tadej Battelino, Charles M Alexander, et al. · The Lancet Diabetes & Endocrinology · 835
Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry
2016 · Agnieszka Szypowska, Anke Schwandt, et al. · Pediatric Diabetes · 125
PDF
International consensus on use of continuous glucose monitoring
2018 · Danne T, Nimri R, et al. · Yearbook of pediatric endocrinology · 44
Diagnóstico do diabetes e rastreamento do diabetes tipo 2
2022 · Roberta Cobas, Melanie Rodacki, et al. · Conectando Pessoas eBooks · 41
PDF
Diagnóstico de diabetes mellitus
2024 · Melanie Rodacki, Roberta A. Cobas, et al. · Conectando Pessoas eBooks · 29
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
2025 · Ketan Dhatariya, Richard M Bergenstal, et al. · The Lancet Diabetes & Endocrinology · 24
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Diabetes Obesity and Metabolism · 23
Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial
2019 · M.A. Czepielewski, Q. Garret, et al. · Growth Hormone & IGF Research · 11
Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge
2017 · For the SWEET Group, Olga Kordonouri, et al. · Acta Diabetologica · 11
Consensus statement on standardizing CGM evaluation metrics in Latin America: an expert approach
2025 · Mauro Scharf, Karen Feriz, et al. · Diabetology & Metabolic Syndrome · 6
PDF
Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement
2021 · M. Rodacki, L. E. Calliari, et al. · Diabetology & Metabolic Syndrome · 6
PDF
Glucose alarms approach with flash glucose monitoring system: a narrative review of clinical benefits
2025 · Marcio Krakauer, Solange Travassos, et al. · Diabetology & Metabolic Syndrome · 4
PDF
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
2020 · M.A. Czepielewski, Q. Garret, et al. · Growth Hormone & IGF Research · 1
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
2026 · Dhatariya K, Bergenstal RM, et al. · Yearbook of pediatric endocrinology
Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study
2026 · Klemen Dovc, Beata Mianowska, et al. · Diabetes Technology & Therapeutics
Sistemas de infusão contínua de insulina
2026 · Emerson Cestari Marino, Monica A. L. Gabbay, et al. · Conectando Pessoas eBooks
Monitorização da glicemia capilar, da glicose intersticial (CGM) e cetonemia capilar em pessoas com Diabetes Mellitus
2026 · Emerson Cestari Marino, Wellington Santana da Silva Júnior, et al. · Conectando Pessoas eBooks
Correction: Consensus statement on standardizing CGM evaluation metrics in Latin america: an expert approach
2025 · Mauro Scharf, Karen Feriz, et al. · Diabetology & Metabolic Syndrome
PDF
Author response for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Publons reviews and discussion
Author response for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"
2019 · Andre G. D. Vianna, Claudio S. Lacerda, et al. · Publons reviews and discussion
Works count: 21
Citation count: 3,231
H-index: 10
I10-index: 10
Year
Topic
Type